1921
Volume 101, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Dengue fever is the most prevalent arbovirus infection among humans, and tropical regions are hyperendemic for this infection. The number of solid organ transplant recipients is continuously increasing, and there are few data regarding the clinical course and outcomes of dengue infection among this population. We report on a retrospective case series of solid organ transplant recipients with dengue virus infection from 2001 to 2018 at Fundación Valle del Lili in Cali, Colombia. A total of 20 patients were included. The median age was 50.5 years (interquartile range [IQR] = 31–63.5 years) and 65% were female. Regarding the clinical course, 75% of patients had at least one warning sign, 45% were managed in the intensive care unit, and 30% had severe dengue. The median of time from transplant and dengue infection was 27.6 months (IQR = 3.82–59.12 months), and three patients had the disease in the first month after the transplant. All patients were discharged, and none of them had graft rejection. Dengue is an endemic disease in our region and represents a threat among solid organ transplantation recipients. All patients had a full recovery after the infection, suggesting that timely and effective management of patients and the access to high-complexity services could prevent fatal cases.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0414
2019-10-14
2021-01-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/6/tpmd190414.html?itemId=/content/journals/10.4269/ajtmh.19-0414&mimeType=html&fmt=ahah

References

  1. Simmons CP, Farrar JJ, van Vinh Chau N, Wills B, 2012. Dengue. N Engl J Med 366: 14231432.
    [Google Scholar]
  2. World Health Organization, Special Programme for Research and Training in Tropical Diseases, 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: WHO.
    [Google Scholar]
  3. World Health Organization, 2012. Global Strategy for Dengue Prevention and Control, 2012–2020. Geneva, Switzerland: WHO.
    [Google Scholar]
  4. Bhatt S et al., 2013. The global distribution and burden of dengue. Nature 496: 504507.
    [Google Scholar]
  5. Vos T et al., 2016. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 15451602.
    [Google Scholar]
  6. Guzman MG, Harris E, 2015. Dengue. Lancet 385: 453465.
    [Google Scholar]
  7. Weerakkody RM, Patrick JA, Sheriff MHR, 2017. Dengue fever in renal transplant patients: a systematic review of literature. BMC Nephrol 18: 16.
    [Google Scholar]
  8. Matesanz R, Mahillo B, Alvarez M, Carmona M, 2009. Global observatory and database on donation and transplantation: world overview on transplantation activities. Transplant Proc 41: 22972301.
    [Google Scholar]
  9. Garcia VD, Garcia CD, Santiago-Delpin EA, 2003. Organ transplants in Latin America. Transplant Proc 35: 16731674.
    [Google Scholar]
  10. Instituto Nacional de Salud, 2018. INS: Cifras de Trasplantes en Colombia Continúan Creciendo. Boletín Prensa Inst Nac Salud, 12. Available at: https://www.ins.gov.co/Comunicaciones/Comunicados de prensa/2018 febrero 9 - Resultados Informe de Donación de Organos.pdf. Accessed April 10, 2019.
    [Google Scholar]
  11. Muller DA, Depelsenaire ACI, Young PR, 2017. Clinical and laboratory diagnosis of dengue virus infection. J Infect Dis 215 (Suppl 2): S89S95.
    [Google Scholar]
  12. World Medical Association, 2013. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310: 21912194.
    [Google Scholar]
  13. Haas M, 2016. The revised (2013) Banff classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations. Am J Transplant 16: 13521357.
    [Google Scholar]
  14. Demetris AJ et al., 2016. 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. Am J Transplant 16: 28162835.
    [Google Scholar]
  15. Tan FL-S, Loh DLSK, Prabhakaran K, 2005. Dengue haemorrhagic fever after living donor renal transplantation. Nephrol Dial Transplant. 20: 447448.
    [Google Scholar]
  16. Garcia JHP, Rocha TDS, Viana CFG, Gonçalves BPA, Girão ES, Vasconcelos JBM, Coelho GR, Schreen D, Costa PEG, Brasil IRC, 2006. Dengue shock syndrome in a liver transplant recipient. Transplantation 82: 850851.
    [Google Scholar]
  17. Renaud CJ, Manjit K, Pary S, 2007. Dengue has a benign presentation in renal transplant patients: a case series. Nephrology 12: 305307.
    [Google Scholar]
  18. Azevedo LS, Carvalho DBM, Matuck T, Alvarenga MF, Morgado L, Magalhaes I, Ianhez LE, Boulos M, David-Neto E, 2007. Dengue in renal transplant patients: a retrospective analysis. Transplantation 84: 792794.
    [Google Scholar]
  19. Prasad N, Bhadauria D, Sharma RK, Gupta A, Kaul A, Srivastava A, 2012. Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak. Transpl Infect Dis 14: 163168.
    [Google Scholar]
  20. Singer M et al., 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3) consensus definitions for sepsis and septic Shock Consensus definitions for sepsis and septic shock. JAMA 315: 801810.
    [Google Scholar]
  21. Wills BA et al., 2005. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 353: 877889.
    [Google Scholar]
  22. Ngo NT et al., 2001. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 32: 204213.
    [Google Scholar]
  23. Nasim A, Anis S, Baqi S, Akhtar SF, Baig-Ansari N, 2013. Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi, Pakistan. Transpl Infect Dis 15: 516525.
    [Google Scholar]
  24. Guzman MG, Alvarez M, Halstead SB, 2013. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158: 14451459.
    [Google Scholar]
  25. Franco-Paredes C, Jacob JT, Hidron A, Rodriguez-Morales AJ, Kuhar D, Caliendo AM, 2010. Transplantation and tropical infectious diseases. Int J Infect Dis 14:e189e196.
    [Google Scholar]
  26. Gupta RK, Gupta G, Chorasiya VK, Bag P, Shandil R, Bhatia V, Wadhawan M, Vij V, Kumar A, 2016. Dengue virus transmission from living donor to recipient in liver transplantation: a case report. J Clin Exp Hepatol 6: 5961.
    [Google Scholar]
  27. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN, 2015. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 125: 616618.
    [Google Scholar]
  28. Mathew A, Woytowitz D, Smith RE, Mehta RP, 2013. Tacrolimus-Induced refractory immune thrombocytopenia in solid organ transplant patients. Blood 122: 2317.
    [Google Scholar]
  29. Cedano JA, Mora BL, Parra-Lara LG, Manzano-Nuñez R, Rosso F, 2019. A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation. Trans R Soc Trop Med Hyg 113: 431436.
    [Google Scholar]
  30. Rosso F, Pineda JC, Sanz AM, Cedano JA, Caicedo LA, 2018. Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review. Braz J Infect Dis 22: 6369.
    [Google Scholar]
  31. Maia SH, Brasil IR, Esmeraldo Rde M, Ponte CN, Costa RC, Lira RA, 2015. Severe dengue in the early postoperative period after kidney transplantation: two case reports from Hospital Geral de Fortaleza. Rev Soc Bras Med Trop 48: 783785.
    [Google Scholar]
  32. Tam DTH et al., 2012. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55: 12161224.
    [Google Scholar]
  33. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S, 1993. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 92: 111115.
    [Google Scholar]
  34. Park SB, Ryu SY, Jin KB, Hwang EA, Han SY, Kim HT, Cho WH, Kwak JH, Ahn KS, Kim HC, 2008. Acute colitis associated with dengue fever in a renal transplant recipient. Transplant Proc 40: 24312432.
    [Google Scholar]
  35. Tangnararatchakit K, Tirapanich W, Tapaneya-Olarn W, Sumethkul V, Sirachainan N, Watcharananan S, Leenanupunth C, Yoksan S, Chuansumrit A, 2012. Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: a case report. Transplant Proc 44: 303306.
    [Google Scholar]
  36. Costa SD, da Silva GB, Jacinto CN, Martiniano LVM, Amaral YS, Paes FJVN, De Mattos Brito Oliveira Sales ML, de Matos Esmeraldo R, De Francesco Daher E, 2015. Dengue fever among renal transplant recipients: a series of 10 cases in a tropical country. Am J Trop Med Hyg 93: 394396.
    [Google Scholar]
  37. Subbiah A, Bagchi S, Bhowmik D, Mahajan S, Yadav RK, Chhabra Y, Agarwal S, 2018. Dengue fever in renal allograft recipients: clinical course and outcome. Transpl Infect Dis 20: 14.
    [Google Scholar]
  38. Kenwar D, Kallepalli V, Ashish S, Singh S, Singh N, Kapoor K, Sandeep C, 2018. Dengue in the renal transplant population–a single center experience. Transplantation 102: S663.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0414
Loading
/content/journals/10.4269/ajtmh.19-0414
Loading

Data & Media loading...

  • Received : 30 May 2019
  • Accepted : 30 Jul 2019
  • Published online : 14 Oct 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error